Eric S. Rosenthal, MD, serves as Medical Director of the Neurosciences Intensive Care Unit at Massachusetts General Hospital.

Dr. Rosenthal is board certified in neurology, neurocritical care, and epilepsy. He sees patients in the MGH Neurosciences ICU, and as part of the MGH Neurology Divisions of Clinical Neurophysiology and Neurocritical Care. His clinical interests include traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), acute stroke, intracerebral hemorrhage, and seizure disorders in critically ill patients, including status epilepticus and seizure-spectrum patterns  

Academically, Dr. Rosenthal is principal investigator of the MGH ICU Precision Medicine Lab, whose mission is to develop treatments to prevent secondary neuronal injury after acute brain injury by characterizing physiologic biomarkers of poor outcome. He performs this work as ICU Director of the MGH Clinical Data Animation Center and as faculty within the Center for Neurotechnology and NeuroRecovery, focusing on acquisition and analysis of telemetry waveform, EEG, medication administration, and contextual electronic health record data, linking these to clinical outcomes. using this data at MGH and through national consortia, his work aims to develop approaches that individualize patient care as well as  develop and test new therapies. This work is supported by the National Institutes of Health and the United States Department of Defense  

Dr. Rosenthal graduated from Harvard Medical School. He completed his residency at the Harvard/Partners Neurology Residency Training Program, and completed fellowships training within the MGH/BWH/Harvard Neurocritical Care Fellowship Training Program, the MGH Epilepsy Fellowship Training Program, and the MGH Clinical Neurophysiology  Fellowship Training Program.